(Q38817543)

6 September 2017

title

MicroRNA-125b suppresses the epithelial-mesenchymal transition and cell invasion by targeting ITGA9 in melanoma (English)

1 reference

6 September 2017

1 reference

Jie Zhang

1

1 reference

6 September 2017

Sijia Na

2

1 reference

6 September 2017

Caiyue Liu

3

1 reference

6 September 2017

Shuting Pan

4

1 reference

6 September 2017

Junying Cai

5

1 reference

6 September 2017

Jiaxuan Qiu

6

1 reference

6 September 2017

publication date

23 November 2015

1 reference

6 September 2017

1 reference

6 September 2017

volume

37

1 reference

6 September 2017

issue

5

1 reference

6 September 2017

page(s)

5941-5949

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-015-4409-8

6 September 2017

exact match

0 references

cites work

The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4409-8

MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4409-8

Many roads to maturity: microRNA biogenesis pathways and their regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4409-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4409-8

MiR-451 inhibits cell growth and invasion by targeting CXCL16 and is associated with prognosis of osteosarcoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4409-8

MicroRNA-320a inhibits cell proliferation, migration and invasion by targeting BMI-1 in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4409-8

MicroRNAs -the next generation therapeutic targets in human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4409-8

MiR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4409-8

Oncomirs - microRNAs with a role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4409-8

Melanoma: diagnosis, staging, and treatment. Consensus group recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4409-8

Corrigendum to "CD44 variant, but not standard CD44 isoforms, mediate disassembly of endothelial VE-cadherin junction on metastatic melanoma cells" [FEBS Lett. 588 (24) (2014) 4573-4582].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4409-8

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4409-8

miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4409-8

An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4409-8

Hsa-miR-125b suppresses bladder cancer development by down-regulating oncogene SIRT7 and oncogenic long non-coding RNA MALAT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4409-8

miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4409-8

miR-125b induces cellular senescence in malignant melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4409-8

The role of miR-125b-mitochondria-caspase-3 pathway in doxorubicin resistance and therapy in human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4409-8

miR-125b inhibitor enhance the chemosensitivity of glioblastoma stem cells to temozolomide by targeting Bak1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4409-8

Integrin α9β1 promotes malignant tumor growth and metastasis by potentiating epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4409-8

Integrin alpha9 (ITGA9) expression and epigenetic silencing in human breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4409-8

Important role of integrins in the cancer biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4409-8

Alpha9beta1 integrin in melanoma cells can signal different adhesion states for migration and anchorage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4409-8

MLK3 promotes melanoma proliferation and invasion and is a target of microRNA-125b

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4409-8

Downregulation of miR-125b in metastatic cutaneous malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4409-8

MicroRNA miR-125b controls melanoma progression by direct regulation of c-Jun protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4409-8

Complex networks orchestrate epithelial-mesenchymal transitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4409-8

The integrin alpha9beta1 on hematopoietic stem and progenitor cells: involvement in cell adhesion, proliferation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4409-8

Integrin alpha9beta1: Unique signaling pathways reveal diverse biological roles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4409-8

Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26596831

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S13277-015-4409-8

1 reference

Dimensions Publication ID

6 September 2017

1035518714

0 references

1 reference